Skip to main content
logo
MBX Biosciences, Inc. (MBX)
NASDAQ: MBX · Real-Time Price · USD
58.51
+1.96 (3.47%)
Oct 2, 2026, 4:00 PM EDT - Market closed

MBX Biosciences Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Net Income
-104.29-86.97-61.92-32.56-26.14
Depreciation & Amortization
0.350.350.240.160.06
Loss (Gain) From Sale of Assets
---0.07-
Loss (Gain) From Sale of Investments
-2.29-3.61-2.93-1.04-0.03
Stock-Based Compensation
16.458.685.222.040.31
Other Operating Activities
0.120.030.110.11.39
Change in Accounts Payable
-2.16-2.463.930.410.67
Change in Other Net Operating Assets
9.154.030.67-1.150.62
Operating Cash Flow
-82.67-79.95-54.68-31.98-23.12
Operating Cash Flow Growth
-----

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Capital Expenditures
-2.53-1.93-0.87-0.13-0.44
Investment in Securities
-178.27-81.78-159.72-30.8-10.97
Investing Cash Flow
-180.8-83.71-160.6-30.93-11.41

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Short-Term Debt Issued
----10
Total Debt Issued
----10
Net Debt Issued (Repaid)
----10
Issuance of Common Stock
279.29190.36174.950.740.03
Other Financing Activities
-1.28-0.77-4.34-0.03-0.46
Financing Cash Flow
278.02189.59234.169.2246.06

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Net Cash Flow
14.5525.9418.836.3111.53

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Free Cash Flow
-85.2-81.88-55.56-32.11-23.56
Free Cash Flow Growth
-----
Free Cash Flow Per Share
-1.97-2.24-5.22-31.52-35.33
Levered Free Cash Flow
-53.01-52.44-33.27-20.56-
Unlevered Free Cash Flow
-53.01-52.44-33.27-20.56-

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Change in Working Capital
6.991.584.6-0.741.29
SEC Filings: 10-K · 10-Q